These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 35108396)

  • 1. Updated meta-analysis of randomized controlled trials on the safety and efficacy of different prophylactic anticoagulation dosing regimens in non-critically ill hospitalized patients with COVID-19.
    Ortega-Paz L; Galli M; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 May; 8(3):E15-E17. PubMed ID: 35108396
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials.
    Ortega-Paz L; Galli M; Capodanno D; Franchi F; Rollini F; Bikdeli B; Mehran R; Montalescot G; Gibson CM; Lopes RD; Andreotti F; Angiolillo DJ
    Eur Heart J Cardiovasc Pharmacother; 2022 Sep; 8(7):677-686. PubMed ID: 34519777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In COVID-19, escalated- vs. prophylactic-dose anticoagulation does not reduce mortality and increases major bleeding.
    Chaudhuri D; Rochwerg B
    Ann Intern Med; 2022 Feb; 175(2):JC18. PubMed ID: 35099996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [COVID-19, anticoagulation and venous thromboembolism: what have we learned ?].
    Blondon M; Robert-Ebadi H
    Rev Med Suisse; 2021 Dec; 17(762):2140-2144. PubMed ID: 34878743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism in Hospitalized COVID-19 Patients.
    Sridharan GK; Vegunta R; Rokkam VRP; Meyyur Aravamudan V; Vegunta R; Khan SR; Ponnada S; Boregowda U; Prudhvi K; Chamarthi G; Mohan BP
    Am J Ther; 2020; 27(6):e599-e610. PubMed ID: 33156016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of higher-intensity dosing of anticoagulation on the clinical outcomes in hospitalized patients with COVID-19: A meta-analysis of randomized controlled trials.
    Kow CS; Ramachandram DS; Hasan SS
    J Infect Chemother; 2022 Feb; 28(2):257-265. PubMed ID: 34840039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The standard of care is standard for a reason: Commentary on "Optimal dosing of heparin for prophylactic anticoagulation in critically ill COVID-19 patients: A systematic review and Meta-analysis of randomized clinical trials".
    Milano V; Hurt J; Nielsen ND
    J Crit Care; 2023 Oct; 77():154345. PubMed ID: 37244208
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of anticoagulation in lowering the mortality in hospitalized covid-19 patients: Meta-analysis of available literature.
    Aamir Waheed M; Rashid K; Rajab T; Rajab A; Adnan AH; Fayyaz H; Ibad AA; Basri R; Khan Y; Alhabib HI; Elzouki A
    Saudi Med J; 2022 Jun; 43(6):541-550. PubMed ID: 35675936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of venous thromboembolism in hospitalized patients with COVID-19.
    Spyropoulos AC
    Blood Adv; 2020 Aug; 4(16):4028. PubMed ID: 32841342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
    Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
    JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venous Thromboembolism in Hospitalized Patients With COVID-19 Receiving Prophylactic Anticoagulation.
    Boonyasai RT; Murthy VK; Yuen-Gee Liu G; Garibaldi BT; Brotman DJ; Streiff MB; Omron R
    Mayo Clin Proc; 2020 Oct; 95(10):2291-2293. PubMed ID: 33012363
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of High-Dose Prophylactic Anticoagulation in Critically Ill Patients With COVID-19 Pneumonia.
    Tacquard C; Mansour A; Godon A; Godet J; Poissy J; Garrigue D; Kipnis E; Rym Hamada S; Mertes PM; Steib A; Ulliel-Roche M; Bouhemad B; Nguyen M; Reizine F; Gouin-Thibault I; Besse MC; Collercandy N; Mankikian S; Levy JH; Gruel Y; Albaladejo P; Susen S; Godier A;
    Chest; 2021 Jun; 159(6):2417-2427. PubMed ID: 33465342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).
    Linnemann B; Bauersachs R; Grebe M; Klamroth R; Müller O; Schellong S; Lichtenberg M
    Vasa; 2020 Jun; 49(4):259-263. PubMed ID: 32501145
    [No Abstract]   [Full Text] [Related]  

  • 15. The Incidence of Venous Thromboembolism in Critically Ill Patients with SARS-CoV-2 Infection Compared with Critically Ill Influenza and Community-Acquired Pneumonia Patients: A Retrospective Chart Review.
    Boyd S; Sheng Loh K; Lynch J; Alrashed D; Muzzammil S; Marsh H; Masoud M; Bin Ihsan S; Martin-Loeches I
    Med Sci (Basel); 2022 Jun; 10(2):. PubMed ID: 35736350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombosis in COVID 2022: An Updated Narrative Review of Current Literature and Inpatient Management.
    Muthiah A; Ohnigian S; Reagan JL; Hsu A
    R I Med J (2013); 2022 Aug; 105(6):36-40. PubMed ID: 35881999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further Evidence Supporting the Use of Prophylactic Anticoagulation in Hospitalized Patients With COVID-19.
    Dicks AB; Weinberg I
    JAMA Netw Open; 2021 Jun; 4(6):e2112403. PubMed ID: 34115133
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].
    Vazquez FJ; Korin J; Baldessari EM; Capparelli FJ; Gutierrez P; Pale C; Bocanegra F; Grand B; Penchasky D; Gonzalez Alcántara MM; Prémoli MS; Tabares A; Wainsztein N; Odetto D; Vaccaro C; Martínez Aquino E; Cumpian O; Falabella V; Antuel García S; Saadi J; Siccardi M; Gándara E
    Medicina (B Aires); 2020; 80 Suppl 3():65-66. PubMed ID: 32658849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism in non-critically ill patients with COVID-19 infection.
    Trimaille A; Curtiaud A; Marchandot B; Matsushita K; Sato C; Leonard-Lorant I; Sattler L; Grunebaum L; Ohana M; Von Hunolstein JJ; Andres E; Goichot B; Danion F; Kaeuffer C; Poindron V; Ohlmann P; Jesel L; Morel O
    Thromb Res; 2020 Sep; 193():166-169. PubMed ID: 32707275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits and harms of direct oral anticoagulation and low molecular weight heparin for thromboprophylaxis in patients undergoing non-cardiac surgery: systematic review and network meta-analysis of randomised trials.
    Marcucci M; Etxeandia-Ikobaltzeta I; Yang S; Germini F; Gupta S; Agarwal A; Ventresca M; Tang S; Morgano GP; Wang M; Ahmed MM; Neumann I; Izcovich A; Criniti J; Popoff F; Devereaux PJ; Dahm P; Anderson D; Lavikainen LI; Tikkinen KAO; Guyatt GH; Schünemann HJ; Violette PD
    BMJ; 2022 Mar; 376():e066785. PubMed ID: 35264372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.